• LAST PRICE
    6.1650
  • TODAY'S CHANGE (%)
    Trending Down-0.1750 (-2.7603%)
  • Bid / Lots
    6.1600/ 7
  • Ask / Lots
    6.1700/ 3
  • Open / Previous Close
    6.3600 / 6.3400
  • Day Range
    Low 6.0300
    High 6.3850
  • 52 Week Range
    Low 3.9801
    High 11.4000
  • Volume
    439,760
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.34
TimeVolumeTERN
09:32 ET96426.385
09:33 ET65706.245
09:35 ET55056.2
09:37 ET7006.22
09:39 ET59846.15
09:42 ET2506.1339
09:44 ET228156.1
09:46 ET44436.11
09:48 ET28736.15
09:50 ET76596.1598
09:51 ET4006.13
09:53 ET186606.1
09:55 ET25216.15
09:57 ET10006.13
10:00 ET36946.115
10:02 ET77276.15
10:04 ET38536.1684
10:06 ET7326.2
10:08 ET20036.19
10:09 ET27026.21
10:11 ET12906.21
10:13 ET35966.2097
10:15 ET50466.19
10:18 ET15336.19
10:20 ET5006.15
10:22 ET60966.13
10:24 ET71566.145
10:26 ET72046.13
10:27 ET118766.08
10:29 ET7006.081
10:31 ET27006.09
10:33 ET86916.08
10:36 ET3006.07
10:38 ET9006.04
10:40 ET75216.04
10:42 ET82376.065
10:44 ET40406.08
10:45 ET107546.1516
10:47 ET2376.15
10:49 ET4166.165
10:51 ET50476.21
10:54 ET51396.195
10:56 ET93036.16
10:58 ET3006.15
11:00 ET13006.145
11:02 ET21006.17
11:03 ET2006.17
11:05 ET26856.18
11:07 ET20006.17
11:09 ET40776.2
11:12 ET23056.21
11:14 ET42206.23
11:16 ET4006.22
11:18 ET11006.21
11:20 ET6006.2
11:21 ET9526.2
11:23 ET3316.21
11:25 ET16176.24
11:27 ET28006.21
11:30 ET3416.215
11:32 ET26416.21
11:34 ET43766.22
11:36 ET33536.21
11:38 ET9826.21
11:39 ET4456.21
11:41 ET12746.22
11:43 ET52546.205
11:45 ET33426.2
11:48 ET7906.2
11:50 ET3006.2
11:52 ET60096.2101
11:54 ET59146.205
11:56 ET8476.215
11:57 ET6006.2
11:59 ET4006.2
12:01 ET33816.2
12:03 ET89146.205
12:06 ET3006.205
12:08 ET13786.2
12:10 ET11076.2
12:12 ET88856.209
12:14 ET123826.205
12:15 ET25856.2
12:17 ET195426.14
12:19 ET63646.165
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTERN
Terns Pharmaceuticals Inc
499.4M
-5.2x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
495.2M
-2.8x
---
United StatesALMS
Alumis Inc
511.4M
-2.1x
---
United StatesKRRO
Korro Bio Inc
515.2M
-3.1x
---
United StatesGHRS
GH Research PLC
482.8M
0.0x
---
United StatesOPT
Opthea Ltd
515.7M
-1.3x
---
As of 2024-11-29

Company Information

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Its pipeline includes three clinical-stage development programs: TERN-701, TERN-601 and TERN-501. TERN-701 is its oral, potent, allosteric BCR-ABL tyrosine kinase inhibitors (TKI) specifically targeting the ABL myristoyl pocket for CML, a form of cancer that begins in the bone marrow and leads to the growth of leukemic cells. TERN-601 is a small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist that is intended to be orally administered for obesity and other metabolic diseases. TERN-501 is a thyroid hormone receptor beta (THR-b) agonist with high metabolic stability and liver distribution. It is also focused on developing the TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity.

Contact Information

Headquarters
1065 East Hillsdale Blvd. Suite 100, Suite 100FOSTER CITY, CA, United States 94404
Phone
650-525-5535
Fax
650-275-4395

Executives

Independent Chairman of the Board
David Fellows
Chief Executive Officer, Director
Amy Burroughs
Chief Financial Officer, Treasurer
Mark Vignola
Chief Development Officer
Scott Harris
Chief Business Officer
Sun Jung

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$499.4M
Revenue (TTM)
$0.00
Shares Outstanding
84.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.36
EPS
$-1.18
Book Value
$3.95
P/E Ratio
-5.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.